Abstract
The existence of the prostate gland and of prostatic disorders was a mystery for many centuries. Nevertheless, the story of diagnosis and treatment of benign prostatic enlargement (BPE) is one of the most relevant issues in urology and perfectly illustrates the evolution of medicine. The gradual increase of life expectancy over the centuries made possible for chronic disorders associated with aging to develop and for their prevalence to grow. Urinary retention was the most ominous complication of prostatic obstruction leading to renal insufficiency, urinary tract infection, and sometimes death of the patient. Initially, the approach to urinary retention mainly consisted in restoring urethral patency by the means of catheters. Invasive BPH treatments were introduced only in the seventeenth and nineteenth century. Undoubtedly, the technological improvement associated with the industrial revolution resulted in the development of sophisticated devices that could be entered in the male urethra to remove the obstructive adenomatous tissue. The availability of lighting systems and current for electrocautery helped to design the modern electroresectoscope and to develop the technique of transurethral resection of the prostate (TURP). Towards the end of the nineteenth century, surgical techniques for prostate removal were proposed and rapidly developed in the new century. A large number of methods and surgical accesses (retropubic, suprapubic, perineal) prove the complexity of the problem for operators. However, thanks to the evolution of these techniques, adenomectomy has been recognized as the appropriate therapeutic method for “large” prostate adenomas. The technologies available today such as laparoscopy or surgical robots “imitate” the principles of adenomectomy developed many years ago.
The pathophysiology of benign prostatic enlargement remains an elusive issue beyond the obvious permissive role of androgens. Lower urinary tract symptoms, once uniquely associated with BPE in the male patient, now recognize different underlying disorders involving the central and peripheral nervous system, the urinary bladder, the prostate, and the pelvic floor. A consensus as to the terminology of LUTS and prostate disorders has been achieved although proper terminology is not always implemented. The diagnosis and management of benign prostatic enlargement and LUTS remains a challenge for the practicing urologist.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mattelaer J, Schultheiss D. Europe – the cradle of urology. Arnhem: History Office of the European Association of Urology; 2010. p. 164–72.
Shelley HS. The enlarged prostate: a brief history of its treatment. J Hist Med Allied Sci. 1969;24:452–73.
Marx FJ, Karenberg A. History of the term prostate. Prostate. 2009;69(2):208–13. PubMed PMID: WOS:000262701200011. English.
Herr HW. The enlarged prostate: a brief history of its surgical treatment. BJU Int. 2006;98(5):947–52. PubMed PMID: 17034596.
Mercier LA. Recherches sur le traitement des maladies organes urinaires. 1856; 36–213.
Oswald LS. The development of the human prostate gland with reference to the development of other structures at the neck of the bladder. Am J Anat. 1912;131:299–349.
Selman SH. The McNeal prostate: a review. Urology. 2011;78(6):1224–8. PubMed PMID: 21908026.
McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol. 1968;49(3):347–57.
McNeal JE. Normal histology of the prostate. Am J Surg Pathol. 1988;12(8):619–33.
Shackley D. A century of prostatic surgery. BJU Int. 1999;83(7):776–82. PubMed PMID: 10368195. English.
Rognon LM, Raymond G. A historical overview of benign prostatic hyperplasia. Ann Urol. 1992;26(3):167–87. PubMed PMID: WOS:A1992JG53200007. French.
Beer E. Removal of neoplasms of the urinary bladder; a new method, employing high-frequency (oudin) currents through a catheterizing cystoscope. Am J Med. 1910;54(22):1768–9.
Stern M. Resection of obstruction at the vesical orifice; new instruments and new method. JAMA. 1926;87(21):1726–30.
McCarthy JF. A new apparatus for endoscopic plastic surgery of the prostate, diathermia and excision of vesical growths. J Urol. 1931;26:695–9.
Nesbit RM. Modification of the Stern-McCarthy resectoscope permitting 3D perception during transurethral prostatectomy. J Urol. 1939;41:646–8.
Hopkins HH, Kapany NS. A flexible fibrescope, using static scanning. Nature. 1954;173((4392):39–41. PubMed PMID: WOS:A1954UA36600025. English.
Emmett JL, Gilbaugh Jr JH, McLean P. Fluid absorption during transurethral resection: comparison of mortality and morbidity after irrigation with water and non-hemolytic solutions. J Urol. 1969;101(6):884–9. PubMed PMID: 5771262.
Goodfellow G. Median perineal prostatectomy. JAMA. 1904;7:194–7.
Proust R. Technique de la prostatectomie périnéale. Ass Franc Urol. 1901;5:361–74.
Young HH. Conservative perineal prostatectomy; a presentation of new instruments and technic. JAMA. 1903;10:999–1009.
Belfield WI. Operation on the enlarged prostate, with a tabulated summary of cases. M J Med Sci. 1890;100:439–52.
McGill AF. Suprapubic prostatectomy. Br Med J. 1887;2:1104–5.
Fuller E. Six successful and successive cases of prostatectomy. J Cutan Genitourin Dis. 1895;6:229–39.
Freyer PJ. A new method of performing perineal prostatectomy. Br Med J. 1900;1(2047):698–9. PubMed PMID: 20758920. Pubmed Central PMCID: 2505977.
Freyer PJ. A clinical lecture on total extirpation of the prostate for radical cure of enlargement of that organ: with four successful cases. Br Med J. 1901;2:125–8.
Blandy JP. Surgery of the benign prostate. First Sir Peter Freyer Memorial Lecture. Ir Med J. 1977;70(17):517–22. PubMed PMID: 338549.
Keynes EL. The control of haemorrhage after prostatectomy. Ann Surg. 1892;16:454–60.
Harris HS. Prostatectomy with complete closure. Med J Aust. 1928;11:288–98.
Harris HS. Suprapubic prostatectomy with closure. Br J Urol. 1929;11:285–9.
Hryntschak T. Suprapubic transvesical prostatectomy with primary closure of the bladder; improved technic and latest results. J Int Coll Surg. 1951;15(3):366–8. PubMed PMID: 14824592.
Millin T. Retropubic prostatectomy; a new extravesical technique; report of 20 cases. Lancet. 1945;2(6380):693–6.
White JW. The results of double castration in the hypertrophy of the prostate. Ann Surg. 1895;22:1–3.
Murphy LJT. The history of urology. Charles C. Thomas: Springfield; 1972.
Abrams P. New words for old: lower urinary tract symptoms for “prostatism”. BMJ (Clin Res). 1994;308(6934):929–30. PubMed PMID: 8173393. Pubmed Central PMCID: PMC2539789. Epub 1994/04/09. eng.
Abrams P, Feneley RCL, Torrens MJ. Urodynamics. Springer Verlag: Berlin; 1984. p. 6–25.
Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–9. PubMed PMID: 6206240. Epub 1984/09/01. eng.
Denis L, McConnell J, Khoury S, et al. Recommendations of the International Scientific Committee: The evaluation and treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction. In: Denis L, Griffiths K, (eds.). Proceedings of the Fourth International Consultation on Benign Prostatic Hyperplasia. Health Publications Ltd.: United Kingdom; 1998; 669–84.
Roehrborn CG. Focus on lower urinary tract symptoms: nomenclature, diagnosis, and treatment options: highlights from the 5th international consultation on benign prostatic hyperplasia June 25–27, 2000, Paris, France. Rev Urol. 2001;3(3):139–45. PubMed PMID: 16985706. Pubmed Central PMCID: PMC1476056. Epub 2006/09/21. eng.
Abrams P, Torrens MJ, Feneley RCL, Cardozo L, Fall M, Griffiths D, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78. PubMed PMID: 11857671. Epub 2002/02/22. eng.
Abrams P, D’ancona C, Griffiths D, et al. Lower Urinary Tract Symptom: Etiology, Patient Assessment and Predicting Outcome from Therapy. In: Mcconnell J, Abrams P, Denis L, Khoury S, Roehrborn C, (eds.). Male lower urinary tract dysfunction. Evaluation and management. Health Publications: Paris; 2006; 71–142.
Chapple CR, Roehrborn CG. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol. 2006;49(4):651–8. PubMed PMID: 16530611. Epub 2006/03/15. eng.
Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. Guidelines on the management of male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO): European Association of Urology. 2012; 6–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Sosnowski, R. (2014). History of LUTS/BPO and Evolution of Concepts and Terminology. In: Chapple, C., Tubaro, A. (eds) Male LUTS/BPH Made Easy. Springer, London. https://doi.org/10.1007/978-1-4471-4688-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4688-9_1
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4687-2
Online ISBN: 978-1-4471-4688-9
eBook Packages: MedicineMedicine (R0)